Catalyst Biosciences Inc. (CBIO)
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
Zomedica Pharmaceuticals Corp (ZOMDF)
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Catalyst Biosciences Inc. (CBIO)
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
Nutex Health Inc (NUTX)
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN
Aoxin Q & M Dental Grp Limited (1D4)
Q & M Dental Group (Singapore) Limited - Announcement
AstraZeneca (AZN)
AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH
Addex Therapeutics Ltd (ADXN)
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
Axogen Inc. (AXGN)
Axogen Announces FDA Approval of Biologics License Application forAVANCE® (acellular nerveallograft–arwx)
Anavex Life Sciences Corp. (AVXL)
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
ResMed Inc (RMD)
ResMed Inc. Daily Stock Update